$17 million lab renovation enables research creativity and innovation

May 16, 2024

A major donation from the Paul Albrechtsen Foundation facilitates the transformation of 20-year-old research laboratories into state-of-the-art facilities housing cutting-edge technology and leading scientists pursuing the next cancer breakthroughs.

Beginning this winter, three floors of the Institute’s cancer research laboratories will undergo major renovations. With the support of renowned architects Diamond Schmitt, the labs will be purpose-built for studying cancer in two significant ways. The first will be to house new technologies or platforms used by cancer researchers. The second is a complete reimagining of physical space to provide an open, collaborative environment for contemporary scientists.

There is a fundamental relationship between the physical research environment and the way scientists think about and collaborate on problems. The new lab removes barriers, providing open spaces where teams work closely together enabling ideation and dialogue as well as sharing of technologies. Dr. Cedric Tremblay, a Principal Investigator comments, “This collaboration is how research happens. Not when we’re looking through the microscope in the lab but when we talk and think together.”

The new lab and access to the latest research technology platforms contribute to recruiting and retaining top scientists, crucial in today’s competitive marketplace. Dr. Yale Michaels, a Principal Investigator raised in Manitoba, trained abroad and returned to the province to research cancer says, “A donation of this magnitude is quite moving. It’s a symbol of optimism that CCMB can be a world-class place to treat and study cancer.”

Ultimately the committed scientists and their teams will be much better equipped to address unmet needs within Manitoba through greater efficiencies, allowing more experiments to be done and completed faster: more science, more research, more advances.

Research Institute News

New book from Institute researcher, Dignity in Care: The Human Side of Medicine helps shape the future of patient care

Senior Scientist at CancerCare Manitoba Research Institute, Dr. Harvey Max Chochinov has published a new book, Dignity in Care: The Human Side of Medicine, providing insight into how the disposition and attitude of healthcare providers indelibly shape patient experience.

Read More

New trial looks at reducing bleeding risk in cancer patients while also developing novel research methods

A new Investigator-Initiated Clinical Trial (IICT) led by Primary Investigator, Dr. Brett Houston, called the MYELO-CAN TXA trial, aims to see whether Tranexamic Acid (TXA) can help prevent bleeding in patients with certain blood cancers such as acute leukemia and myelodysplastic syndrome.

Read More

Advanced magnetic resonance simulator to bring new options for research and treatment

The Institute has acquired a state-of-the-art magnetic resonance simulator (MR-SIM) to be installed in 2024, made possible by generous community donations. The research applications of this technology will include new patient treatment techniques and workflows.

Read More